Literature DB >> 26452561

Incidence of postoperative residual neuromuscular blockade after general anesthesia: a prospective, multicenter, anesthetist-blind, observational study.

Buwei Yu1, Baoyi Ouyang2, Shengjin Ge3, Yan Luo1, Jun Li4, Dongmei Ni5, Shuangfei Hu6, Hui Xu7, Jin Liu8, Su Min9, Longyun Li10, Zhengliang Ma11, Kangjie Xie12, Changhong Miao13, Xinmin Wu5.   

Abstract

OBJECTIVE: Evidences demonstrate that postoperative residual neuromuscular blockade (rNMB) is a primary and frequent anesthetic risk factor for postoperative complications. This study was designed to mitigate the paucity of data regarding the occurrence and degree of rNMB in a real-life setting.
METHODS: This prospective, multicenter, anesthetist-blind, observational study enrolled 1571 Chinese adults undergoing elective open or laparoscopic abdominal surgery lasting ≤4 hours from 32 hospitals across China. The patients received anesthesia in accordance with routine practice at the study site. Neuromuscular blockade (NMB) was monitored using acceleromyography, with rNMB defined as a train-of-four (TOF) ratio <0.9.
RESULTS: The patients' mean age was 46 years and 71% were female. The procedures included laparoscopic (67%), open abdominal (31%), and laparoscopic to open abdominal (2%). NMB was reversed with neostigmine in 78% of patients. The overall incidence of rNMB at extubation was 57.8%, and the proportions of participant with TOF ratios <0.6, 0.6-0.7, 0.7-0.8, 0.8-0.9 were 22.9%, 6.9%, 11.1% and 16.9%, respectively, immediately prior to endotracheal extubation. Age <45 years (OR = 0.630, 95% CI = 0.496-0.801, p = 0.002), use of one neuromuscular blocking agent (NMBA) (OR = 0.387, 95% CI = 0.243-0.618, p < 0.0001), time from neostigmine administration to endotracheal extubation ≥10 min (OR = 0.513, 95% CI = 0.400-0.658, p < 0.0001) and time from last NMBA administration to endotracheal extubation ≥60 min (OR = 0.902, 95% CI = 0.801-0.989, p = 0411) were correlated with non-rNMB at the time of extubation.
CONCLUSIONS: This observational study demonstrated that the overall incidence of rNMB at the time of endotracheal extubation was high in Chinese patients undergoing abdominal procedures, which necessitates appropriate management in current real-life practice. CLINICAL TRIAL REGISTRY NUMBER: NCT01871064.

Entities:  

Keywords:  General anesthesia; Observational study; Residual neuromuscular blockade; Train-of-four monitoring

Mesh:

Substances:

Year:  2015        PMID: 26452561     DOI: 10.1185/03007995.2015.1103213

Source DB:  PubMed          Journal:  Curr Med Res Opin        ISSN: 0300-7995            Impact factor:   2.580


  11 in total

1.  Efficacy and safety of neostigmine for neuromuscular blockade reversal in patients under general anesthesia: a systematic review and meta-analysis.

Authors:  Wentao Ji; Xiaoting Zhang; Jia Liu; Guolin Sun; Xiandong Wang; Lulong Bo; Xiaoming Deng
Journal:  Ann Transl Med       Date:  2021-11

Review 2.  [Algorithm-based preventive strategies for avoidance of residual neuromuscular blocks].

Authors:  C Unterbuchner; K Ehehalt; B Graf
Journal:  Anaesthesist       Date:  2019-11       Impact factor: 1.041

3.  A Clinical and Budgetary Impact Analysis of Introducing Sugammadex for Routine Reversal of Neuromuscular Blockade in a Hypothetical Cohort in the US.

Authors:  Yiling Jiang; Lori D Bash; Leif Saager
Journal:  Adv Ther       Date:  2021-04-19       Impact factor: 3.845

4.  Utilization Patterns of Perioperative Neuromuscular Blockade Reversal in the United States: A Retrospective Observational Study From the Multicenter Perioperative Outcomes Group.

Authors:  Timur Z Dubovoy; Leif Saager; Nirav J Shah; Douglas A Colquhoun; Michael R Mathis; Steven Kapeles; Graciela Mentz; Sachin Kheterpal; Michelle T Vaughn
Journal:  Anesth Analg       Date:  2020-11       Impact factor: 6.627

5.  Economic analysis of sugammadex versus neostigmine for reversal of neuromuscular blockade for laparoscopic surgery in China.

Authors:  Maodong Ren; Ying Wang; Yan Luo; Jia Fang; Yongji Lu; Jianwei Xuan
Journal:  Health Econ Rev       Date:  2020-11-14

6.  Recovery of early postoperative muscle strength after deep neuromuscular block by means of ultrasonography with comparison of neostigmine versus sugammadex as reversal drugs: study protocol for a randomised controlled trial.

Authors:  Xuan Wang; Yingyuan Li; Chanyan Huang; Wei Xiong; Qin Zhou; Lijun Niu; Ying Xiao
Journal:  BMJ Open       Date:  2021-02-26       Impact factor: 2.692

7.  Peri-operative diaphragm ultrasound as a new method of recognizing post-operative residual curarization.

Authors:  Jiaxin Lang; Yuchao Liu; Yuelun Zhang; Yuguang Huang; Jie Yi
Journal:  BMC Anesthesiol       Date:  2021-11-19       Impact factor: 2.217

Review 8.  Sugammadex, the Guardian of Deep Muscle Relaxation During Conventional and Robot-Assisted Laparoscopic Surgery: A Narrative Review.

Authors:  Yan Sun; Zhilin Wu; Qi Wang; Rui Chen; Shujun Sun; Yun Lin
Journal:  Drug Des Devel Ther       Date:  2021-09-14       Impact factor: 4.162

9.  Comparison of the effects of neostigmine and sugammadex on postoperative residual curarization and postoperative pulmonary complications by means of diaphragm and lung ultrasonography: a study protocol for prospective double-blind randomized controlled trial.

Authors:  Yu-Guan Zhang; Ying Chen; Yue-Lun Zhang; Jie Yi
Journal:  Trials       Date:  2022-05-07       Impact factor: 2.279

10.  Neuromuscular Blocking Agents and Monitoring in China: A Cross-Sectional Survey of Current Management.

Authors:  HaoTian Wu; ZengMao Lin; RuiHao Zhou; SuiSui Huang; LingJun Chen; Yang Su; LuoNa Cheng; Huan Zhang
Journal:  Front Med (Lausanne)       Date:  2022-04-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.